Otcbb, Pink Sheet, Nasdaq, Nyse, and AMEX traded hot penny stocks to find our readers the most relevant Hot Penny Stocks. Please visit our site frequently as we are continuously adding new hot penny stock profiles.   We provide merchant banking services, and reverse mergers to management teams and corporations interested in long- term success, and integrity. Venture Capital Partners acts as a primary consultant or deal sponsor and is responsible for all of the corporate finance activities. We will arrange the financing, advise on acquisitions, help recruit management, coordinate the legal and accounting advisors, select underwriters, and provide ongoing strategic advice through board representation.


Home  Financing   Profiled   Otcbb News   About Us   Trading Myths   Pink Sheets   Links   Contact

Penny Stocks
Penny Stock archives

Disclaimer

PennyMarkets.com information should not be construed as investment advice. PennyMarkets.com and its affiliates are not investment advisors. Penny Stocks are risky investments, and investors can lose all of their investment. Before making any investment decision please consult an investment advisor. Here is a link to several investment advisors!

Friday, June 17, 2005

 

Penny Stocks ACTH Advanced Cell Technology Expands Senior Scientific Team into California

ACTH Advanced Cell Technology Expands Senior Scientific Team into California: "ACTH Advanced Cell Technology Expands Senior Scientific Team into California


WORCESTER, Mass.--(BUSINESS WIRE)--June 17, 2005--Michael West, Ph.D., President and Chief Scientific Officer of A.C.T. Holdings, Inc. (OTCBB:ACTH) and its wholly-owned subsidiary, Advanced Cell Technology, Inc. (collectively, 'ACT') announced today the expansion of ACT's senior scientific team with the addition of senior scientists that will add to the existing California team. California research is an increasing focus for ACT, given voters recently approved $3 billion in state funds for stem cell research.


David Larocca, Ph.D., Associate Director
Previously Associate Director of Research at Selective Genetics, Inc., Dr. Larocca brings more than 20 years experience in biotechnology and discovery research to Advanced Cell Technology. In his former position, Dr. Larocca invented novel gene therapy methods using bacterial viruses and novel technology for discovering drug targeting agents and their receptors. He holds over a dozen patents in the fields of functional genomics, gene delivery and cancer immunotherapy. He received a Ph.D. from the University of Southern California in Cell and Molecular Biology and did his postdoctoral studies at Harvard University.
James T. Murai, Ph.D., Associate Director
With more than 38 published scientific papers and formerly Senior Scientist at Immunetech, Inc., Dr. Murai has extensive background and experience in biochemistry and reproductive endocrinology and a successful track record in assay development and problem solving in a variety of research areas including immunology/allergy, reproductive endocrinology, and end"

Otcbb News and Informatuion About the OTCBB trading platform, and listing information.

Penny Stocks Trading Information Learn about how penny stocks generally trade, and how to avoid the big mistake.

Pink Sheets Listing, and Trading Information Learn about the Pink Sheets, and how they can help your company move forward.

ACTH Information, Stock Tips, Stock Picks, Investing Online, Day TradingNews, Charts, and More on ACTH


This page is powered by Blogger. Isn't yours?



Penny Stocks   Financing   Profiled   Otcbb Info   About Penny Stocks    Penny Stock Trading Myths   Pink Sheets   Penny Stock L inks   Contact